MED Medgold Resources Corp

Medgold Resources Corp. (TSX VENTURE:MED), the European focused gold exploration
company, is pleased to announce that it has been awarded the Boticas exploration
licence in northern Portugal by the Direcao-Geral de Energia e Geologia (DGEG)
of Portugal.


Dan James, the President of the Company, commented: "We're delighted that the
Boticas licence has been awarded and I would like to thank the DGEG and the
Portuguese government for their continued support. We now plan to fast-track the
project to resource definition using the wealth of historical data collected
over the last three decades. In parallel, we will start exploring the wider
licence area where we have numerous untested gold anomalies. We believe this
work will add substantial value for our shareholders over the next two years. In
addition to our new Boticas licence, we also have our other Portuguese asset,
Vila de Rei, which hosts multiple strike-extensive, gold-bearing silica ribs.
These two 100% owned licences represent very exciting exploration projects with
potential in each to host significant gold mineralization."


The Boticas Licence

The 106 square kilometer Boticas licence covers approximately 12 km strike
length of a major regional structure that is considered to control orogenic gold
mineralization. The Limarinho prospect, which has been the focus of historic
exploration, is orientated orthogonal to this major structure, and is considered
to be a major dilational, or 'crumple-zone', which is of sufficient scale to
potentially host a multi-million ounce gold system. Furthermore, and typical of
orogenic gold systems, these dilational zones commonly repeat along major
regional structures creating a series of en echelon mineralized zones which
opens up additional exploration potential.


Recent reconnaissance sampling completed by Medgold has identified a new zone of
mineralization located 200 m to the southeast of the Limarinho prospect, with
five grab samples yielding best results of 13.1 g/t, 8.19 g/t and 0.80 g/t Au.
Early indications suggest that this zone may be an en echelon zone off-set from,
and parallel to, the main Limarinho zone. This zone will be the focus of further
investigation over the summer.


Previous licence-wide exploration, undertaken by COGEMA of France in the 1980s,
which involved detailed grid-soil sampling, identified 15 gold anomalies
throughout the licence, of which only three were drill-tested. Drilling was
undertaken by COGEMA in the late 1980s and Kernow Resources & Developments Ltd
("Kernow") in the early and late 2000s, with both companies primarily focusing
on the Limarinho prospect. Drilling defined gold mineralization over at least
600 metres in strike and 150 metres in width, remaining open in both directions,
and drill-tested to a vertical depth of greater than 150 metres, yet also
remains open at depth. Historical drilling results(i) reported by both companies
include:




--  40.2m at 1.96 g/t Au from 19.3m, including 20.4m at 2.92 g/t Au from
    20.7m (hole KL4);
--  50.05m at 1.70 g/t Au from 8.65m, including 19.7m @ 2.80 g/t Au from
    32.2m (hole PF3), and;
--  104.75m at 0.83 g/t Au from 45.50 to 150.25m (hole PF17).



(i) Historic reports indicate a total of 3,234 metres of diamond drilling was
completed in 26 holes. These are historical data provided for information
purposes and Medgold has not completed sufficient work to verify these results.


The historic drilling indicates that Limarinho has a higher grade core of gold
mineralization, as evidenced by Kernow's hole KL4 which returned 20.4m at 2.92
g/t Au, and Medgold's channel sample yielding 3.98 g/t Au over 14.10m (as
reported by Medgold press release 5 February 2013), which is surrounded by a
broad zone of roughly 1 g/t Au mineralization. Previous mineralization studies
indicated that the gold is typically free, associated with a late mineral phase,
with gold grains occupying micro-fractures, highlighting potential for high
percentage gold recoveries.


Proposed Work

Medgold's field work will continue through the summer with an initial focus upon
the newly discovered zone located 200m to the southeast of Limarinho by detailed
mapping and channel-chip sampling. Licence-wide exploration will also be
undertaken to explore for repeating zones of mineralization along the structural
corridor of the main NE-trending fault. At the same time, detailed structural
studies will be initiated to better understand the mechanical controls upon the
gold mineralization. Medgold hopes to outline a number of drill targets for
testing later in the year.


Quality Assurance and Quality Control (QA-QC)

Medgold's samples were prepared by ALS Minerals at the Seville Laboratory,
Spain. Samples were analysed for gold by fire assay with atomic adsorption
finish by ALS Minerals at the Rosia Montana Laboratory, Romania. Multi-elements
were analyzed by inductively coupled plasma mass spectrometer (ICP-MS) and
inductively coupled plasma emission spectrometer (ICP-AES) on a sample split
sent to the ALS Minerals laboratory in Vancouver. Certified reference materials
(CRM's), blanks and field and laboratory duplicates were routinely inserted for
quality assurance and quality control.


Qualified Person

Dr. Stewart D. Redwood, Consulting Geologist to the Company, is a Qualified
Person as defined by National Instrument 43-101 - Standards of Disclosure or
Mineral Projects. Dr. Redwood has reviewed and approved the technical
information contained in this news release.


About Medgold

Medgold is aiming to become the leading Mediterranean-focused gold exploration
and project development company, with an extensive portfolio and pipeline of
projects across Portugal, Italy and Spain, targeting economically stressed, but
politically stable European countries that are seeking foreign investment to
invigorate the mining sector.


Additional information on Medgold can be found on the Company's website at
www.Medgoldresources.com and by reviewing the Company's page on SEDAR at
www.sedar.com.


ON BEHALF OF THE BOARD

Ralph Rushton, Director

Neither the TSX Venture Exchange nor the Investment Industry Regulatory
Organization of Canada accepts responsibility for the adequacy or accuracy of
this release.


Forward-looking statements

This news release may contain forward-looking statements including, but not
limited to, comments regarding the timing and content of upcoming work programs,
geological interpretations, receipt of property titles, potential mineral
recovery processes, and other related matters. Forward-looking statements
address future events and conditions and therefore involve inherent risks and
uncertainties. Medgold's projects in Europe are at an early stage and all
estimates and projections are based on limited, and possibly incomplete, data.
More work is required before the mineralization and the projects' economic
aspects can be confidently modelled. Actual results may differ materially from
those currently anticipated in this news release. No representation or
prediction is intended as to the results of future work, nor can there be any
promise that the estimates and projections herein will be sustained in future
work or that the projects will otherwise prove to be economic. Medgold disclaims
any intention or obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Medgold Resources Corp.
Ralph Rushton (Vancouver)
Investor Relations
+1 604-801-5432
ralphr@goldgroup.com


Medgold Resources Corp.
Dan James (London)
President
+44 (0) 207 305 7050 / +44 (0) 7972 579188
dj@medgoldresources.com
www.Medgoldresources.com

Grafico Azioni Medgold Resources (TSXV:MED)
Storico
Da Apr 2024 a Mag 2024

Grafico Azioni Medgold Resources (TSXV:MED)
Storico
Da Mag 2023 a Mag 2024